Related Experiment Video
Updated: Aug 9, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Treatment options for early Parkinson's disease
1University of Missouri-Columbia School of Medicine, USA.
American Family Physician
|March 1, 1996
Summary
Accurate diagnosis is key for tremor treatment. Essential tremor affects movement, while Parkinson
Area of Science:
- Neurology
- Movement Disorders
- Pharmacology
Background:
- Tremor diagnosis is crucial for effective clinical management.
- Essential tremor (familial tremor) is characterized by movement affecting limbs, head, and voice.
- Parkinson's disease tremor occurs at rest, impacting the jaw and limbs, and is linked to bradykinesia, rigidity, and falls.
Purpose of the Study:
- To differentiate between essential tremor and Parkinson's disease tremor.
- To outline current treatment strategies for Parkinson's disease.
- To discuss the role of various medications in managing Parkinson's disease symptoms.
Main Methods:
- Differential diagnosis based on tremor characteristics (resting vs. action).
- Review of pharmacological treatments for Parkinson's disease.
- Discussion of adjunctive therapies for early-stage Parkinson's disease.
Main Results:
- Levodopa, a dopamine precursor, is the most effective treatment for Parkinson's disease.
- Early-stage Parkinson's disease may benefit from neuroprotective agents, dopamine agonists, dopamine reuptake inhibitors, anticholinergics, and amantadine.
- Polypharmacy is frequently required to manage side effects and optimize symptom control.
Conclusions:
- Correct diagnosis is fundamental for appropriate tremor management.
- Parkinson's disease management involves a multi-faceted pharmacological approach.
- Combination therapy is often necessary to address the complexities of Parkinson's disease.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...